Related Experiment Videos
Corporate climate risk and public health disclosure: does digital transformation matter?
Jiana Liu1, Zhifeng Jie2, Yan Wan1
1Business School, Jiangxi Institute of Fashion Technology, Nanchang, China.
Introduction:
Climate risk is playing an increasingly important role in shaping corporate behavior and non-financial disclosure. This study examines the nonlinear relationship between corporate climate risk (CR) and public health disclosure (PHD) using panel data from Chinese listed companies over the period 2000-2024.
Methods:
Empirically, this study employs a two-way fixed effects model, a moderating effect model, and a quantile regression model, accompanied by formal cross-quantile tests to evaluate the non-linear dynamics, moderating channels, and heterogeneity across conditional PHD distributions.
Results:
Four key findings emerge. First, CR exhibits a U-shaped relationship with PHD, and this relationship remains robust after a series of robustness and endogeneity checks. Second, conditional marginal effects and digital transformation (DT) specific turning points show that DT changes both the level and shape of the CR-PHD relationship, shifting the turning point to the right and attenuating the recovery of PHD at higher CR levels. Third, formal cross-quantile tests confirm that the CR and its quadratic term coefficients differ across the conditional PHD distribution. Fourth, the same tests identify significant differences across marketization and return on assets groups, whereas the differences across marginal profit groups are not statistically supported.
Discussion:
These findings highlight the role of corporate CR and technological capabilities in shaping PHD. The U-shaped dynamic indicates that moderate CR initially depresses PHD, whereas severe risk forces strategic transparency to restore stakeholder trust and corporate reputation. Furthermore, the moderating effect of DT underscores that digital capabilities buffer firms against immediate risk pressures, altering their disclosure thresholds. The observed heterogeneity across marketization levels and financial performance emphasizes the need for differentiated regulatory oversight that accounts for regional institutional environments and corporate resource slack in driving sustainable corporate transparency.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Dimensions of Health and Illness
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Ethical Standards I
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
Microbes and Climate Change
Ethical Issues
Ethical Concerns in Healthcare: